共有 50 笔近期内部人交易记录记录，涉及 Cingulate Inc. (CINGW), 包括 42 笔买入 和 6 笔卖出. 内部人买入总额为 $3.66M 内部人卖出总额为 $841.33.
近期活跃的重要内部人包括 Schaffer Shane J., Silva Raul R., Callahan Jennifer L.. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — CINGW
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-09 |
Schaffer Shane J. |
Chief Executive Officer |
RSU 预扣税 |
2,959 |
- |
- |
4,076 |
| 2026-03-09 |
Silva Raul R. |
EVP and CSO |
RSU 预扣税 |
1,828 |
- |
- |
4,645 |
| 2026-03-09 |
Callahan Jennifer L. |
EVP and CFO |
RSU 预扣税 |
6,427 |
- |
- |
13,961 |
| 2026-03-09 |
Brams Matthew |
EVP and Chief Medical Officer |
RSU 预扣税 |
1,025 |
- |
- |
8,157 |
| 2026-03-09 |
Patel Nilay Dahyabhai |
EVP, CLO and Cco |
RSU 预扣税 |
2,086 |
- |
- |
3,389 |
| 2026-02-06 |
Schaffer Shane J. |
Chief Executive Officer |
知情买入 |
5,447 |
$5.04 |
$27.45K |
5,447 |
| 2026-02-06 |
Werth Peter J. |
Director |
知情买入 |
15,564 |
$5.04 |
$78.44K |
15,564 |
| 2026-02-06 |
Callahan Jennifer L. |
SVP and CFO |
知情买入 |
3,891 |
$5.04 |
$19.61K |
3,891 |
| 2026-02-06 |
Brams Matthew |
EVP and Chief Medical Officer |
知情买入 |
1,556 |
$5.04 |
$7.84K |
1,556 |
| 2025-12-31 |
Silva Raul R. |
EVP and CSO |
限制性股票授予 (RSU) |
6,625 |
$4.34 |
$28.75K |
6,625 |
| 2025-11-03 |
Downey Bryan Wade |
Officer |
未知 |
- |
- |
- |
- |
| 2025-11-03 |
Downey Bryan Wade |
Chief Commercial Officer |
限制性股票授予 (RSU) |
30,000 |
$3.80 |
$114K |
30,000 |
| 2025-09-30 |
Silva Raul R. |
EVP and CSO |
限制性股票授予 (RSU) |
7,334 |
$3.92 |
$28.75K |
7,334 |
| 2025-07-08 |
Patel Nilay Dahyabhai |
Officer |
未知 |
- |
- |
- |
- |
| 2025-07-08 |
Patel Nilay Dahyabhai |
CLO and Cco |
限制性股票授予 (RSU) |
30,000 |
$4.51 |
$135.3K |
30,000 |
| 2025-07-07 |
Schaffer Shane J. |
Chief Executive Officer |
限制性股票授予 (RSU) |
199,500 |
$4.42 |
$881.79K |
199,500 |
| 2025-07-07 |
Silva Raul R. |
EVP and CSO |
限制性股票授予 (RSU) |
51,500 |
$4.42 |
$227.63K |
51,500 |
| 2025-07-07 |
Callahan Jennifer L. |
SVP and CFO |
限制性股票授予 (RSU) |
64,500 |
$4.42 |
$285.09K |
64,500 |
| 2025-07-07 |
Myers Laurie |
EVP and COO |
限制性股票授予 (RSU) |
31,000 |
$4.42 |
$137.02K |
31,000 |
| 2025-07-07 |
Brams Matthew |
EVP and Chief Medical Officer |
限制性股票授予 (RSU) |
52,500 |
$4.42 |
$232.05K |
52,500 |
| 2025-06-30 |
Silva Raul R. |
EVP and CSO |
限制性股票授予 (RSU) |
1,000 |
$4.07 |
$4.07K |
1,000 |
| 2025-06-20 |
Roberts John A |
Director |
限制性股票授予 (RSU) |
15,000 |
$4.14 |
$62.1K |
15,000 |
| 2025-06-20 |
Ervin Jeffrey S |
Director |
限制性股票授予 (RSU) |
15,000 |
$4.14 |
$62.1K |
15,000 |
| 2025-06-20 |
Werth Peter J. |
Director |
限制性股票授予 (RSU) |
15,000 |
$4.14 |
$62.1K |
15,000 |
| 2025-06-20 |
Lawrence Bryan Jay |
Director |
限制性股票授予 (RSU) |
15,000 |
$4.14 |
$62.1K |
15,000 |
| 2025-03-31 |
Silva Raul R. |
EVP and CSO |
限制性股票授予 (RSU) |
1,000 |
$4.30 |
$4.3K |
1,000 |
| 2025-02-18 |
Schaffer Shane J. |
Chief Executive Officer |
限制性股票授予 (RSU) |
70,489 |
$4.32 |
$304.51K |
70,489 |
| 2025-02-18 |
Silva Raul R. |
EVP and CSO |
限制性股票授予 (RSU) |
17,630 |
$4.32 |
$76.16K |
17,630 |
| 2025-02-18 |
Callahan Jennifer L. |
SVP and CFO |
限制性股票授予 (RSU) |
21,140 |
$4.32 |
$91.32K |
21,140 |
| 2025-02-18 |
Myers Laurie |
EVP and COO |
限制性股票授予 (RSU) |
17,630 |
$4.32 |
$76.16K |
17,630 |
| 2025-02-18 |
Brams Matthew |
EVP and Chief Medical Officer |
限制性股票授予 (RSU) |
17,630 |
$4.32 |
$76.16K |
17,630 |
| 2025-01-17 |
Schaffer Shane J. |
Chief Executive Officer |
限制性股票授予 (RSU) |
27,638 |
$4.76 |
$131.56K |
27,638 |
| 2025-01-17 |
Silva Raul R. |
EVP and CSO |
限制性股票授予 (RSU) |
2,748 |
$4.76 |
$13.08K |
2,748 |
| 2025-01-17 |
Callahan Jennifer L. |
SVP and CFO |
限制性股票授予 (RSU) |
11,539 |
$4.76 |
$54.93K |
11,539 |
| 2025-01-17 |
Myers Laurie |
EVP and COO |
限制性股票授予 (RSU) |
9,319 |
$4.76 |
$44.36K |
9,319 |
| 2025-01-17 |
Brams Matthew |
EVP and Chief Medical Officer |
限制性股票授予 (RSU) |
2,748 |
$4.76 |
$13.08K |
2,748 |
| 2024-12-31 |
Silva Raul R. |
EVP and CSO |
限制性股票授予 (RSU) |
1,000 |
$4.93 |
$4.93K |
1,000 |
| 2024-12-31 |
Brams Matthew |
EVP and Chief Medical Officer |
限制性股票授予 (RSU) |
1,000 |
$4.93 |
$4.93K |
1,000 |
| 2024-09-30 |
Silva Raul R. |
EVP and CSO |
限制性股票授予 (RSU) |
1,000 |
$5.04 |
$5.04K |
1,000 |
| 2024-09-30 |
Brams Matthew |
EVP and Chief Medical Officer |
限制性股票授予 (RSU) |
1,000 |
$5.04 |
$5.04K |
1,000 |
| 2024-08-15 |
Myers Laurie |
EVP and COO |
知情卖出 |
202 |
$4.17 |
$841.33 |
- |
| 2024-06-28 |
Silva Raul R. |
EVP and CSO |
限制性股票授予 (RSU) |
1,000 |
$0.32 |
$320.00 |
1,000 |
| 2024-06-28 |
Brams Matthew |
EVP and Chief Medical Officer |
限制性股票授予 (RSU) |
1,000 |
$0.32 |
$320.00 |
1,000 |
| 2024-06-12 |
Roberts John A |
Director |
限制性股票授予 (RSU) |
10,000 |
$0.70 |
$7K |
10,000 |
| 2024-06-12 |
Ervin Jeffrey S |
Director |
限制性股票授予 (RSU) |
10,000 |
$0.70 |
$7K |
10,000 |
| 2024-06-12 |
Werth Peter J. |
10 Percent Owner |
限制性股票授予 (RSU) |
10,000 |
$0.70 |
$7K |
10,000 |
| 2024-06-12 |
Lawrence Bryan Jay |
Director |
限制性股票授予 (RSU) |
10,000 |
$0.70 |
$7K |
10,000 |
| 2024-06-11 |
Roberts John A |
Director |
限制性股票授予 (RSU) |
5,000 |
$1.18 |
$5.9K |
5,000 |
| 2024-06-11 |
Ervin Jeffrey S |
Director |
限制性股票授予 (RSU) |
5,000 |
$1.18 |
$5.9K |
5,000 |
| 2024-06-11 |
Schaffer Shane J. |
Chief Executive Officer |
限制性股票授予 (RSU) |
217,677 |
$1.18 |
$256.86K |
217,677 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
